Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods
BACKGROUND: DCLK1, as the most potential colorectal cancer stem cell (CSC) marker has been the core of many recent investigations. However, no study has been performed to evaluate the circulating cellular DCLK1 protein (CCDP) that might reflect the presences of colorectal CSC in circulation. OBJECTI...
Gespeichert in:
| Veröffentlicht in: | Cancer biomarkers : section A of Disease markers 2016-09, Vol.17 (3), p.301-311 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 311 |
|---|---|
| container_issue | 3 |
| container_start_page | 301 |
| container_title | Cancer biomarkers : section A of Disease markers |
| container_volume | 17 |
| creator | Mirzaei, Alireza Madjd, Zahra Kadijani, Azade Amini Tavakoli-Yaraki, Masoumeh Modarresi, Mohammad Hossein Verdi, Javad Akbari, Abolfazl Tavoosidana, Gholamreza |
| description | BACKGROUND:
DCLK1, as the most potential colorectal cancer stem cell (CSC) marker has been the core of many recent investigations. However, no study has been performed to evaluate the circulating cellular DCLK1 protein (CCDP) that might reflect the presences of colorectal CSC in circulation.
OBJECTIVES:
We aimed to evaluate CCDP in the peripheral blood mononuclear cells (PBMCs) of colorectal cancer (CRC) patients applying immunoassay based methods including PLA, IPCR and ELISA in order to introduce the method of choice for clinical detection of CCDP.
METHODS:
PBMCs were extracted from blood samples of 58 CRC patients along with 58 blood samples of tumor free controls. Total protein of PBMC was extracted and the CCDP level was evaluated. The results of three applied immunoassay tests were compared and the best approach for clinical application was introduced, accordingly. In addition, the correlation of CCD Plevel with clincopathologic findings of CRC patients was assessed.
RESULTS:
The results of three immuneassay methods confirmed each other. Based on our finding, ELISA could be the most judicious method for clinical evaluation of CCDP considering its simplicity for clinical implications. Our results also showed a significant higher amount of CCDP in peripheral blood of CRC patients compared to control group which was also correlated with patients' clinicopathologic finding such as stage, grade and neoadjuvant history.
CONCLUSION:
CCDP could be applied for monitoring purposes in CRC patients. However, its application needs to be more elucidated in future investigations implementing larger samples. |
| doi_str_mv | 10.3233/CBM-160642 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_1834999827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3233_CBM-160642</sage_id><sourcerecordid>1834999827</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-8e0fbef7004208e5569449fb925e0a1bb20c9446f972fb3d570bf6befa69d3a73</originalsourceid><addsrcrecordid>eNptkMlOwzAURS0EYt7wAcg7EGrAQyYvoZRBFLGBdeQ4zyWQxGA7SP0GfhqnKaxYvUHnXb17ETqi5Jwzzi-mV48RTUkasw20S_MsifJEsM3QJ1kcEZrwHbTn3BshMadMbKMdluWEMZLuou_Zl2x66WvTYaOxqq3qmzB2C6ygaUJv8fV0_kDxhzUe6m6CpcP-FXBrnB-Wbe1WtGmMBeVlg5XsFFjsPLQrEdxK-w52gvsVWbdt3xnpnFziUjqocAv-1VTuAG1p2Tg4XNd99HIze57eRfOn2_vp5TxSnAof5UB0CToLdhjJIUlSEcdCl4IlQCQtS0ZU2KRaZEyXvEoyUuo0XMhUVFxmfB-djrrh-88enC-Ch-FR2YHpXUFzHgshcjagZyOqrHHOgi4-bB3sLAtKiiH8IoRfjOEH-Hit25ctVH_ob9oBOBkBJxdQvJnedsHnf1I_C5yNSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834999827</pqid></control><display><type>article</type><title>Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods</title><source>Sage Journals GOLD Open Access 2024</source><creator>Mirzaei, Alireza ; Madjd, Zahra ; Kadijani, Azade Amini ; Tavakoli-Yaraki, Masoumeh ; Modarresi, Mohammad Hossein ; Verdi, Javad ; Akbari, Abolfazl ; Tavoosidana, Gholamreza</creator><creatorcontrib>Mirzaei, Alireza ; Madjd, Zahra ; Kadijani, Azade Amini ; Tavakoli-Yaraki, Masoumeh ; Modarresi, Mohammad Hossein ; Verdi, Javad ; Akbari, Abolfazl ; Tavoosidana, Gholamreza</creatorcontrib><description>BACKGROUND:
DCLK1, as the most potential colorectal cancer stem cell (CSC) marker has been the core of many recent investigations. However, no study has been performed to evaluate the circulating cellular DCLK1 protein (CCDP) that might reflect the presences of colorectal CSC in circulation.
OBJECTIVES:
We aimed to evaluate CCDP in the peripheral blood mononuclear cells (PBMCs) of colorectal cancer (CRC) patients applying immunoassay based methods including PLA, IPCR and ELISA in order to introduce the method of choice for clinical detection of CCDP.
METHODS:
PBMCs were extracted from blood samples of 58 CRC patients along with 58 blood samples of tumor free controls. Total protein of PBMC was extracted and the CCDP level was evaluated. The results of three applied immunoassay tests were compared and the best approach for clinical application was introduced, accordingly. In addition, the correlation of CCD Plevel with clincopathologic findings of CRC patients was assessed.
RESULTS:
The results of three immuneassay methods confirmed each other. Based on our finding, ELISA could be the most judicious method for clinical evaluation of CCDP considering its simplicity for clinical implications. Our results also showed a significant higher amount of CCDP in peripheral blood of CRC patients compared to control group which was also correlated with patients' clinicopathologic finding such as stage, grade and neoadjuvant history.
CONCLUSION:
CCDP could be applied for monitoring purposes in CRC patients. However, its application needs to be more elucidated in future investigations implementing larger samples.</description><identifier>ISSN: 1574-0153</identifier><identifier>EISSN: 1875-8592</identifier><identifier>DOI: 10.3233/CBM-160642</identifier><identifier>PMID: 27802206</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Aged ; Biomarkers, Tumor ; Case-Control Studies ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - pathology ; Female ; Humans ; Intracellular Signaling Peptides and Proteins - metabolism ; Leukocytes, Mononuclear - metabolism ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Neoplastic Stem Cells - metabolism ; Protein-Serine-Threonine Kinases - metabolism ; Reproducibility of Results ; ROC Curve ; Young Adult</subject><ispartof>Cancer biomarkers : section A of Disease markers, 2016-09, Vol.17 (3), p.301-311</ispartof><rights>IOS Press and the authors. All rights reserved</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-8e0fbef7004208e5569449fb925e0a1bb20c9446f972fb3d570bf6befa69d3a73</citedby><cites>FETCH-LOGICAL-c319t-8e0fbef7004208e5569449fb925e0a1bb20c9446f972fb3d570bf6befa69d3a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.3233/CBM-160642$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.3233/CBM-160642$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21945,27830,27901,27902,44921,45309</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.3233/CBM-160642?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27802206$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mirzaei, Alireza</creatorcontrib><creatorcontrib>Madjd, Zahra</creatorcontrib><creatorcontrib>Kadijani, Azade Amini</creatorcontrib><creatorcontrib>Tavakoli-Yaraki, Masoumeh</creatorcontrib><creatorcontrib>Modarresi, Mohammad Hossein</creatorcontrib><creatorcontrib>Verdi, Javad</creatorcontrib><creatorcontrib>Akbari, Abolfazl</creatorcontrib><creatorcontrib>Tavoosidana, Gholamreza</creatorcontrib><title>Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods</title><title>Cancer biomarkers : section A of Disease markers</title><addtitle>Cancer Biomark</addtitle><description>BACKGROUND:
DCLK1, as the most potential colorectal cancer stem cell (CSC) marker has been the core of many recent investigations. However, no study has been performed to evaluate the circulating cellular DCLK1 protein (CCDP) that might reflect the presences of colorectal CSC in circulation.
OBJECTIVES:
We aimed to evaluate CCDP in the peripheral blood mononuclear cells (PBMCs) of colorectal cancer (CRC) patients applying immunoassay based methods including PLA, IPCR and ELISA in order to introduce the method of choice for clinical detection of CCDP.
METHODS:
PBMCs were extracted from blood samples of 58 CRC patients along with 58 blood samples of tumor free controls. Total protein of PBMC was extracted and the CCDP level was evaluated. The results of three applied immunoassay tests were compared and the best approach for clinical application was introduced, accordingly. In addition, the correlation of CCD Plevel with clincopathologic findings of CRC patients was assessed.
RESULTS:
The results of three immuneassay methods confirmed each other. Based on our finding, ELISA could be the most judicious method for clinical evaluation of CCDP considering its simplicity for clinical implications. Our results also showed a significant higher amount of CCDP in peripheral blood of CRC patients compared to control group which was also correlated with patients' clinicopathologic finding such as stage, grade and neoadjuvant history.
CONCLUSION:
CCDP could be applied for monitoring purposes in CRC patients. However, its application needs to be more elucidated in future investigations implementing larger samples.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor</subject><subject>Case-Control Studies</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Staging</subject><subject>Neoplastic Stem Cells - metabolism</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Reproducibility of Results</subject><subject>ROC Curve</subject><subject>Young Adult</subject><issn>1574-0153</issn><issn>1875-8592</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMlOwzAURS0EYt7wAcg7EGrAQyYvoZRBFLGBdeQ4zyWQxGA7SP0GfhqnKaxYvUHnXb17ETqi5Jwzzi-mV48RTUkasw20S_MsifJEsM3QJ1kcEZrwHbTn3BshMadMbKMdluWEMZLuou_Zl2x66WvTYaOxqq3qmzB2C6ygaUJv8fV0_kDxhzUe6m6CpcP-FXBrnB-Wbe1WtGmMBeVlg5XsFFjsPLQrEdxK-w52gvsVWbdt3xnpnFziUjqocAv-1VTuAG1p2Tg4XNd99HIze57eRfOn2_vp5TxSnAof5UB0CToLdhjJIUlSEcdCl4IlQCQtS0ZU2KRaZEyXvEoyUuo0XMhUVFxmfB-djrrh-88enC-Ch-FR2YHpXUFzHgshcjagZyOqrHHOgi4-bB3sLAtKiiH8IoRfjOEH-Hit25ctVH_ob9oBOBkBJxdQvJnedsHnf1I_C5yNSQ</recordid><startdate>20160926</startdate><enddate>20160926</enddate><creator>Mirzaei, Alireza</creator><creator>Madjd, Zahra</creator><creator>Kadijani, Azade Amini</creator><creator>Tavakoli-Yaraki, Masoumeh</creator><creator>Modarresi, Mohammad Hossein</creator><creator>Verdi, Javad</creator><creator>Akbari, Abolfazl</creator><creator>Tavoosidana, Gholamreza</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160926</creationdate><title>Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods</title><author>Mirzaei, Alireza ; Madjd, Zahra ; Kadijani, Azade Amini ; Tavakoli-Yaraki, Masoumeh ; Modarresi, Mohammad Hossein ; Verdi, Javad ; Akbari, Abolfazl ; Tavoosidana, Gholamreza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-8e0fbef7004208e5569449fb925e0a1bb20c9446f972fb3d570bf6befa69d3a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor</topic><topic>Case-Control Studies</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Staging</topic><topic>Neoplastic Stem Cells - metabolism</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Reproducibility of Results</topic><topic>ROC Curve</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mirzaei, Alireza</creatorcontrib><creatorcontrib>Madjd, Zahra</creatorcontrib><creatorcontrib>Kadijani, Azade Amini</creatorcontrib><creatorcontrib>Tavakoli-Yaraki, Masoumeh</creatorcontrib><creatorcontrib>Modarresi, Mohammad Hossein</creatorcontrib><creatorcontrib>Verdi, Javad</creatorcontrib><creatorcontrib>Akbari, Abolfazl</creatorcontrib><creatorcontrib>Tavoosidana, Gholamreza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer biomarkers : section A of Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mirzaei, Alireza</au><au>Madjd, Zahra</au><au>Kadijani, Azade Amini</au><au>Tavakoli-Yaraki, Masoumeh</au><au>Modarresi, Mohammad Hossein</au><au>Verdi, Javad</au><au>Akbari, Abolfazl</au><au>Tavoosidana, Gholamreza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods</atitle><jtitle>Cancer biomarkers : section A of Disease markers</jtitle><addtitle>Cancer Biomark</addtitle><date>2016-09-26</date><risdate>2016</risdate><volume>17</volume><issue>3</issue><spage>301</spage><epage>311</epage><pages>301-311</pages><issn>1574-0153</issn><eissn>1875-8592</eissn><abstract>BACKGROUND:
DCLK1, as the most potential colorectal cancer stem cell (CSC) marker has been the core of many recent investigations. However, no study has been performed to evaluate the circulating cellular DCLK1 protein (CCDP) that might reflect the presences of colorectal CSC in circulation.
OBJECTIVES:
We aimed to evaluate CCDP in the peripheral blood mononuclear cells (PBMCs) of colorectal cancer (CRC) patients applying immunoassay based methods including PLA, IPCR and ELISA in order to introduce the method of choice for clinical detection of CCDP.
METHODS:
PBMCs were extracted from blood samples of 58 CRC patients along with 58 blood samples of tumor free controls. Total protein of PBMC was extracted and the CCDP level was evaluated. The results of three applied immunoassay tests were compared and the best approach for clinical application was introduced, accordingly. In addition, the correlation of CCD Plevel with clincopathologic findings of CRC patients was assessed.
RESULTS:
The results of three immuneassay methods confirmed each other. Based on our finding, ELISA could be the most judicious method for clinical evaluation of CCDP considering its simplicity for clinical implications. Our results also showed a significant higher amount of CCDP in peripheral blood of CRC patients compared to control group which was also correlated with patients' clinicopathologic finding such as stage, grade and neoadjuvant history.
CONCLUSION:
CCDP could be applied for monitoring purposes in CRC patients. However, its application needs to be more elucidated in future investigations implementing larger samples.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>27802206</pmid><doi>10.3233/CBM-160642</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1574-0153 |
| ispartof | Cancer biomarkers : section A of Disease markers, 2016-09, Vol.17 (3), p.301-311 |
| issn | 1574-0153 1875-8592 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1834999827 |
| source | Sage Journals GOLD Open Access 2024 |
| subjects | Adult Aged Biomarkers, Tumor Case-Control Studies Colorectal Neoplasms - metabolism Colorectal Neoplasms - pathology Female Humans Intracellular Signaling Peptides and Proteins - metabolism Leukocytes, Mononuclear - metabolism Male Middle Aged Neoplasm Grading Neoplasm Staging Neoplastic Stem Cells - metabolism Protein-Serine-Threonine Kinases - metabolism Reproducibility of Results ROC Curve Young Adult |
| title | Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A47%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20circulating%20cellular%20DCLK1%20protein,%20as%20the%20most%20promising%20colorectal%20cancer%20stem%20cell%20marker,%20using%20immunoassay%20based%20methods&rft.jtitle=Cancer%20biomarkers%20:%20section%20A%20of%20Disease%20markers&rft.au=Mirzaei,%20Alireza&rft.date=2016-09-26&rft.volume=17&rft.issue=3&rft.spage=301&rft.epage=311&rft.pages=301-311&rft.issn=1574-0153&rft.eissn=1875-8592&rft_id=info:doi/10.3233/CBM-160642&rft_dat=%3Cproquest_AFRWT%3E1834999827%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834999827&rft_id=info:pmid/27802206&rft_sage_id=10.3233_CBM-160642&rfr_iscdi=true |